Skip to main content
. Author manuscript; available in PMC: 2023 Jun 1.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2022 Feb 12;113(2):335–344. doi: 10.1016/j.ijrobp.2022.02.014

Table 1.

Patient and Treatment Characteristics

Characteristic All Patients (n = 89)
No. of Patients (%)

Median age, range 68 (46 – 83)

Smoking History
 Never 19 (21)
 Former 66 (74)
 Current 4 (5)

Sex at Birth
 Female 57 (64)
 Male 32 (36)

Performance Status
 ECOG 0 54 (61)
 ECOG 1 35 (39)

Histology
 Adenocarcinoma 78 (88)
 Squamous Cell 6 (7)
 Other 5 (5)

Tumor Mutational Burden
 Median, IQR (mt/Mb) 7 (3.5 – 11.63)

AJCC 8th Overall Stage
 I 1 (1)
 IIB 7 (8)
 IIIA 67 (75)
 IIIB 14 (16)

Surgery Type
 Wedge / Segmentectomy 8 (9)
 Lobectomy 79 (89)
 Pneumonectomy 2 (2)

Margin Status
 Negative 78 (88)
 Positive 11 (12)

Involved Mediastinal Nodal Stations
 0 10 (11)
 1 53 (60)
 2 23 (26)
 3 3 (3)

Chemotherapy
 Yes 79 (89)
 Neoadjuvant 32 (46)
 Adjuvant 46 (52)

Neo/Adjuvant ICI
 Yes 12 (14)

Adjuvant TKI
 Yes 10 (11)

Radiation Dose
 Median, range (Gy) 54 (50 – 60)

Radiation Technique
 3D-CRT 18 (20)
 IMRT 71 (80)